Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-16.41%
0%
-16.41%
6 Months
-2.98%
0%
-2.98%
1 Year
-1.21%
0%
-1.21%
2 Years
24.43%
0%
24.43%
3 Years
-10.44%
0%
-10.44%
4 Years
56.73%
0%
56.73%
5 Years
207.55%
0%
207.55%
Limes Schlosskliniken AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
35.82%
EBIT Growth (5y)
53.99%
EBIT to Interest (avg)
3.88
Debt to EBITDA (avg)
0.34
Net Debt to Equity (avg)
-0.02
Sales to Capital Employed (avg)
1.57
Tax Ratio
21.97%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
34.93%
ROE (avg)
30.48%
Valuation key factors
Factor
Value
P/E Ratio
20
Industry P/E
Price to Book Value
5.03
EV to EBIT
16.07
EV to EBITDA
11.48
EV to Capital Employed
4.83
EV to Sales
2.68
PEG Ratio
0.69
Dividend Yield
NA
ROCE (Latest)
30.05%
ROE (Latest)
24.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
37.40
28.80
29.86%
Operating Profit (PBDIT) excl Other Income
4.70
8.70
-45.98%
Interest
0.00
0.40
-100.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
3.00
4.90
-38.78%
Operating Profit Margin (Excl OI)
125.70%
208.20%
-8.25%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 29.86% vs 23.08% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -38.78% vs 19.51% in Dec 2022
About Limes Schlosskliniken AG 
Limes Schlosskliniken AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






